BIANCO, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 87.854
NA - Nord America 1.991
AS - Asia 727
SA - Sud America 101
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 90.719
Nazione #
IT - Italia 87.304
US - Stati Uniti d'America 1.968
CN - Cina 310
SG - Singapore 256
SE - Svezia 147
UA - Ucraina 140
DE - Germania 106
BR - Brasile 76
FI - Finlandia 52
VN - Vietnam 44
GB - Regno Unito 42
IN - India 36
MA - Marocco 17
CA - Canada 13
PK - Pakistan 13
FR - Francia 12
AR - Argentina 11
JP - Giappone 11
BD - Bangladesh 10
PL - Polonia 10
KR - Corea 9
HK - Hong Kong 8
BE - Belgio 7
MX - Messico 7
LT - Lituania 6
EG - Egitto 5
ID - Indonesia 5
NL - Olanda 5
RU - Federazione Russa 5
TN - Tunisia 5
ZA - Sudafrica 5
ES - Italia 4
NG - Nigeria 4
PT - Portogallo 4
SA - Arabia Saudita 4
TR - Turchia 4
AT - Austria 3
CO - Colombia 3
EU - Europa 3
JO - Giordania 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
VE - Venezuela 3
CZ - Repubblica Ceca 2
ET - Etiopia 2
IQ - Iraq 2
KE - Kenya 2
TW - Taiwan 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CM - Camerun 1
EC - Ecuador 1
GE - Georgia 1
GT - Guatemala 1
IL - Israele 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SL - Sierra Leone 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 90.719
Città #
Cagliari 86.263
Uta 958
Fairfield 198
Ashburn 176
Woodbridge 148
Chandler 128
Singapore 127
Houston 110
Nyköping 107
Seattle 98
Wilmington 85
Dallas 82
Ann Arbor 78
Beijing 69
Boardman 66
Dearborn 61
Cambridge 59
Jacksonville 55
Los Angeles 47
Shanghai 39
Helsinki 32
Boston 27
Santa Clara 27
New York 26
Nanjing 25
Dong Ket 18
Redwood City 17
Casablanca 16
Munich 15
The Dalles 15
Chennai 13
Council Bluffs 13
Shenyang 12
Hefei 11
San Diego 11
Ho Chi Minh City 10
London 9
Seoul 9
Buffalo 8
Nanchang 8
Phoenix 8
Tianjin 8
Warsaw 8
Brussels 7
Hebei 7
Hong Kong 7
Jiaxing 7
Mountain View 7
Multan 7
San Francisco 7
São Paulo 7
Changsha 6
Frankfurt am Main 6
Hanoi 6
Herndon 6
Jinan 6
Tokyo 6
Verona 6
Atlanta 5
Rome 5
Zhengzhou 5
Brooklyn 4
Chicago 4
Columbus 4
Denver 4
Ibadan 4
Jakarta 4
Johannesburg 4
Mumbai 4
Ottawa 4
Pune 4
Redmond 4
Rio de Janeiro 4
Sassari 4
Walnut 4
Amman 3
Amsterdam 3
Auburn Hills 3
Betim 3
Greater Noida 3
Guangzhou 3
Guarulhos 3
La Jolla 3
Mexico City 3
Montreal 3
Ningbo 3
Norwalk 3
Portsmouth 3
Saint Petersburg 3
Toronto 3
Turku 3
Washington 3
Wuhan 3
Zagazig 3
Bauru 2
Bengaluru 2
Can Tho 2
Curitiba 2
Düsseldorf 2
Governador Valadares 2
Totale 89.538
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.693
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.029
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.657
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.408
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.351
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.293
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.148
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.901
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.739
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.711
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.507
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.486
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.337
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.162
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 2.988
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.870
MD protocol validation for the study of MAOB-inhibitor complexes 2.738
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.710
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.597
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.572
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.506
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.394
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.038
Structure-based approaches applied to the study of pharmaceutical relevant targets 1.012
Totale 90.847
Categoria #
all - tutte 100.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.170 0 0 0 0 0 2.086 1.176 1.126 604 1.292 1.247 639
2021/20223.573 441 281 177 324 325 189 184 175 334 399 364 380
2022/20235.424 422 849 778 571 353 550 226 340 307 281 381 366
2023/20244.513 314 162 376 270 407 827 502 386 290 236 341 402
2024/202518.698 8.046 5.226 3.011 806 411 515 386 37 82 46 47 85
2025/2026857 141 94 202 136 165 119 0 0 0 0 0 0
Totale 90.847